We are a biotechnology company pioneering RNA-based therapeutics to address high unmet medical needs in cardiovascular, metabolic, rare liver, and rare kidney diseases. Our proprietary DARGER™ platform enables both gene upregulation and downregulation using novel antisense oligonucleotide (ASO) and small interfering RNA (siRNA) approaches.
Company Details
- Employees
- 9
- Founded
- -
- Address
- 10355 Science Center Dr, San Diego,california 92121,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.arnatar.com
- Keywords
- La Jolla.
- HQ
- San Diego, California
Arnatar Therapeutics Questions
Arnatar Therapeutics's website is https://www.arnatar.com
Arnatar Therapeutics's LinkedIn profile is https://www.linkedin.com/company/arnatar-therapeutics
Arnatar Therapeutics has
9 employees.
View email and phone details for 9
employees at Arnatar Therapeutics.
Arnatar Therapeutics's industry is
Biotechnology Research
Arnatar Therapeutics's top competitors are
Salk Institute For Biological Studies,
Precision Quantomics,
Farmacious,
3e Bioventures,
Cerevora Therapeutics Inc.,
Thefeld And Associates,
Retrocirc Technologies,
Artiva Biotherapeutics,
Denali Therapeutics,
Biomed Linkage Tech Co., Limited.
Arnatar Therapeutics's categories are Biotechnology Research
Arnatar Therapeutics's founding year is 2022
